De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C-Reference-Cited by-同舟云学术

De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C

Published:2007-11-06 Issue:3 Volume:27 Page:257-265
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

MARTÍN-SANTOS R.,DÍEZ-QUEVEDO C.,CASTELLVÍ P.,NAVINÉS R.,MIQUEL M.,MASNOU H.,SOLER A.,ARDEVOL M.,GARCÍA F.,GALERAS J. A.,PLANAS R.,SOLÀ R.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2007.03568.x/fullpdf

Reference46 articles.

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994;Alter;N Engl J Med,1999

2. Epidemiology of hepatitis C in the United States;Williams;Am J Med,1999

3. Hepatocellular carcinoma: an epidemiologic view;El-Serag;J Clin Gastroenterol,2002

4. Hepatitis C virus infection;Lauer;N Engl J Med,2001

5. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome;Alter;Semin Liver Dis,2000

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO study;BMC Infectious Diseases;2024-02-23

2. Fatores associados à adesão ao tratamento da hepatite C: revisão integrativa;Ciência & Saúde Coletiva;2022-04

3. Association of serum interleukin-6 and C-reactive protein with depressive and adjustment disorders in COVID-19 inpatients;Brain, Behavior, & Immunity - Health;2022-02

4. Perceived Discrimination, Experiential Avoidance, and Mental Health among Hispanic Adults in Primary Care;Transcultural Psychiatry;2022-01-12

5. Depressive and Anxious Symptoms in Hepatitis C Virus Infected Patients Receiving DAA-Based Therapy;Diagnostics;2021-11-29